Obstructive sleep apnea (OSA) is one of the most common causes of hypertension 18 in western societies. OSA causes chronic intermittent hypoxia (CIH) in specialized O 2 -19 sensing glomus cells of the carotid body. CIH generates increased reactive oxygen 20 species (ROS) that trigger a feed-forward mechanism in which increased intracellular 21 calcium levels ([Ca 2+ ] i ) trigger increased HIF-1α synthesis and increased HIF-2α 22 degradation. As a result, the normal homeostatic balance between HIF-1α-dependent pro-23 oxidant and HIF-2α-dependent anti-oxidant enzymes is disrupted, leading to further 24 increases in ROS. Carotid body sensory nerves project to the nucleus tractus solitarius, 25 from which the information is relayed via interneurons to the rostral ventrolateral medulla 26 in the brainstem, which sends sympathetic neurons to the adrenal medulla to stimulate the 27 release of epinephrine and norepinephrine, catecholamines that increase blood pressure. 28
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At each synapse, neurotransmitters trigger increased [Ca 2+ ] i , HIF-1α:HIF-2α and 29
Nox2:Sod2 activity that generates increased ROS levels. These responses are not 30 observed in other regions of the brainstem that do not receive input from the carotid body 31 or signal to the sympathetic nervous system. Thus, sympathetic nervous system 32 PATIENTS WITH OBSTRUCTIVE SLEEP APNEA (OSA) experience episodes of 38 upper airway collapse during sleep that result in periods of hypoxemia (usually 15-30 39 seconds in duration) leading to arousal, clearing of the airway, and reoxygenation. These 40 episodes of hypoxemia and reoxygenation are repeated dozens of times each night. 41 Several large population-based studies have demonstrated that OSA is associated with an 42 increased incidence of hypertension (11, 24) . OSA is the most common secondary cause 43 of resistant hypertension (12). Among OSA patients, the use of continuous positive 44 airway pressure (CPAP) during sleep was associated with a reduced risk of hypertension 45 compared to untreated OSA patients, but the incidence of hypertension was still higher 46 than in control subjects (9) . 47
Experimental models. Considerable progress has been made in understanding the 48 pathogenesis of hypertension in OSA patients through the use of animal models, which 49 have demonstrated that exposure of rodents to repetitive, brief episodes of hypoxia and 50 reoxygenation is sufficient to induce hypertension. Thus, although OSA patients 51 experience both chronic intermittent hypoxia (CIH) and chronic intermittent 52 hypercapnea, CIH (in the absence of hypercapnea) is a sufficient pathophysiological 53 stimulus to cause hypertension (2, 3) and co-exposure to both hypoxia and hypercapnia 54 has no additional effect (8). Remarkably, the duration of the reoxygenation phase is more 55 important than the duration of the hypoxia phase (26) and protocols in which the 56 reoxygenation phase is longer than the hypoxia phase are more effective in eliciting 57 hypertension than protocols with hypoxia and reoxygenation phases of equal duration 58
(17).
Neural circuitry activated by chronic intermittent hypoxia. Bilateral transection of 60 the carotid sinus nerve completely prevented the hypertension that was observed in sham-61 operated rats subjected to CIH for 35 days, demonstrating the essential role of carotid 62 body chemoreceptors (2). The glomus cell chemoreceptors send signals via the carotid 63 sinus nerve to the nucleus tractus solitarius, from which interneurons project to the rostral 64 ventrolateral medulla in the brainstem (7, 22) , from which efferent signals are sent via 65 spinal nerves that synapse in sympathetic ganglia and then are transmitted via the adrenal 66 sympathetic nerve (a branch of the splanchnic nerve) leading to stimulation of the adrenal 67 medulla to secrete catecholamines (epinephrine and norepinephrine), which increase 68 blood pressure (BP) (Fig. 1) were placed in an environmental chamber in which the O 2 concentration was rapidly 90 dropped from 21% to 5% for 15 seconds and then rapidly increased to 21% for 5 minutes, 91
and this hypoxia-reoxygenation cycle was repeated for 8 hours per day over 10 days, 92 which caused an increase in mean BP from ~110 to >140 mmHg in WT mice but no 93 significant BP increase in Hif1a littermates (15). The increase in BP was associated 94 with a significant increase in plasma catecholamine levels in WT mice subjected to CIH, 95 but not in in Hif1a littermates (15). Whereas Hif1a mice with partial HIF-1α 96 deficiency fail to develop hypertension in response to CIH, Epas1 mice with partial 97
HIF-2α deficiency manifest hypertension even under normoxic conditions (13). 98
Analysis of WT mice exposed to CIH revealed that HIF-1α levels increased in the 99 carotid body (15), whereas HIF-2α levels decreased (10). The cycles of hypoxia and 100 reoxygenation during CIH cause an increase in reactive oxygen species (ROS) (16). ROS 101 generated during CIH increase intracellular calcium levels [Ca 2+ ] i , leading to protein 102 kinase C (PKC)-dependent induction of mTOR (mammalian target of rapamycin) activity 103 that increased HIF-1α expression (15, 28), which led to increased expression of the Nox2 104 gene encoding the pro-oxidant enzyme NADPH oxidase (27) . ROS generated by Nox2has been shown to interfere with the normal function of mitochondrial electron transport 106 complex I, resulting in a further increase in ROS generation (5 ;Hif1a compound heterozygous mice, which are partially 117 deficient for both HIF-1α and HIF-2α, had completely normal BP and carotid body 118 responses to hypoxia (29), demonstrating that it is the ratio of HIF-1α to HIF-2α that 119 determines the set point of carotid body reactivity, thereby controlling sympathetic 120 activation and BP (Fig. 2) . 121
Intermittent hypoxia is transduced to intermittent neural activity. In addition to 122 the remarkable finding that CIH increased HIF-1α and Nox2 expression, decreased HIF-123 2α and Sod2 expression, and increased oxidative stress in glomus cells of the carotid 124 body, the same changes were observed in neurons of the nTS and RVLM, but not in 125 nearby brainstem regions that do not receive input from the carotid body, as well as in 126 chromaffin cells of the adrenal medulla (14). These findings suggested either that cells in 127 the nTS, RVLM, and adrenal medulla directly sense and respond to CIH, in a mannersimilar to the carotid body, or that neural activity induces the same response in these cells 129 that are induced by CIH in the carotid body. 130
To test whether carotid body neural activity is required for downstream effects, 131 rats were subjected to carotid body ablation. CIH induced increased HIF-1α protein and 132
Nox2 activity and decreased HIF-2α protein and Sod2 activity in nTS, RVLM, and 133 adrenal medulla of control rats but not in rats subjected to carotid body ablation (14). CIH 134 induced increased adrenal sympathetic nerve activity in response to a subsequent episode 135 acute hypoxia and this response was lost in rats subjected to carotid body ablation; 136 responses in the adrenal medulla were also lost in rats subjected to adrenal sympathetic 137 nerve ablation (14) . 138
In the adrenal medulla, sympathetic nerves release acetylcholine, which binds to 139 muscarinic or nicotinic acetylcholine receptors on the surface of the catecholamine-140 secreting chromaffin cells. Treatment of rats with atropine during a 10-day exposure to 141 CIH had no effect on carotid body or adrenal sympathetic nerve activity but blocked the 142 response of the adrenal medulla to CIH, indicating that muscarinic acetylcholine 143 receptors mediate the effects of the sympathetic nervous system on chromaffin cells of 144 the adrenal medulla (14) . 145
To further analyze the response of chromaffin cells to sympathetic activation, the 146 rat PC12 pheochromocytoma cell line, which was originally established from a tumor of 147 rat adrenal medullary chromaffin cells, was studied. Repetitive, intermittent application 148 of muscarine (5-minute treatment followed by 10-minute washout for 3 cycles) was 149 sufficient to increase HIF-1α and decrease HIF-2α protein levels, and the effect was 150 blocked by atropine. In contrast, repetitive, intermittent application of nicotine, orconstant application of muscarine or nicotine, had no effect (14). Repetitive, intermittent 152 muscarine application increased [Ca 2+ ] i and mTOR activity and these responses, which 153 were blocked by atropine, were required for induction of HIF-1α protein expression 154 because muscarine did not induce HIF-1α expression in the presence of the calcium 155 chelator BAPTA-AM or the mTOR inhibitor rapamycin. Repetitive, intermittent 156 muscarine treatment of PC12 cells also increased calpain activity and the calpain 157 inhibitor Ac-LLM-CHO blocked HIF-2α degradation that was induced by muscarine 158 treatment (14). Consistent with the PC12 studies, analysis of adrenal medulla from rats 159 subjected to CIH revealed increased activity of mTOR and calpains, which provide a 160 basis for increased HIF-1α and decreased HIF-2α levels, respectively, and these effects 161 were blocked by carotid body ablation, adrenal sympathetic nerve ablation, or atropine 162
treatment (14). 163
As expected, the increase in plasma catecholamines and BP that are induced by 164 CIH were not observed in rats that were subjected to carotid body ablation or adrenal 165 sympathetic nerve ablation. These results demonstrate that the response of the adrenal 166 medulla is dependent of transmission of neural signals generated in the carotid body in 167 response to CIH. Remarkably, unlike adrenal medulla from control rats, which is 168 unresponsive, sections of adrenal medulla from CIH-exposed rats increased 169 catecholamine secretion when subjected to hypoxia ex vivo (14). It is also interesting that 170 in PC12 cells, increased HIF-1α  Nox2 and decreased HIF-2α  Sod2 signaling can 171 be induced either by intermittent hypoxia (10, 14) or repetitive, intermittent muscarine 172 application (14), highlighting the interconversion of ROS signals and neural activity thatSummary. Studies in rodents indicate that the relative steady state levels of HIF-175 1α and HIF-2α protein in O 2 -sensing glomus cells of the carotid body determine the set 176 point of sympathetic nervous system activity and blood pressure in healthy individuals. In 177 patients with OSA, CIH increases ROS, which trigger increased [Ca 2+ ] i leading to 178 increased PKC-dependent mTOR activity and increased calpain activity, which cause 179 increased HIF-1α and decreased HIF-2α levels, leading to increased Nox2 and decreased 180 Sod2 activity that together further increase ROS in the carotid body in a feed-forward 181 mechanism (Fig. 2) . Increased [Ca 2+ ] i also results in the depolarization of glomus cells 182 leading to increased activity of neurons that project to the nTS and from there to the 183 RVLM in the brainstem, where they synapse with sympathetic neurons that project via 184 the spinal cord to sympathetic ganglia, where they synapse with neurons that project via 185 the adrenal sympathetic nerve to activate muscarinic receptors on chromaffin cells in the 186 adrenal medulla and stimulate their release into the circulation of epinephrine and 187 norepinephrine, which are catecholamines that cause vasoconstriction and thereby 188 increase BP (Fig. 1) . Clinical studies have also demonstrated impaired endothelium-189 dependent vasodilation in OSA patients (19) , but it is not known whether this defect is a 190 direct effect of CIH on endothelial cells or a secondary effect of increased circulating 191
catecholamines. 192
Whereas glomus cells in the carotid body respond directly to ROS resulting from 193 CIH, neurons in the nTS, RVLM, and adrenal medulla depolarize in response to 194 neurotransmitters and the resulting increased [Ca 2+ ] i triggers an increase in HIF-1α:HIF-195 2α expression and Nox2:Sod2 activity that results in ROS generation as well as signal 196 transmission that ultimately results in catecholamine release and hypertension (Fig. 2) .
Thus, sympathetic nervous system homeostasis is dependent on a balance between HIF-198 1α and HIF-2α levels, the disruption of which results in oxidative stress and 199 hypertension. These studies have delineated the molecular and cellular mechanisms that 200 underlie the most common cause of treatment-resistant hypertension in western society. 201
Drugs that inhibit HIF-1α but not HIF-2α, such as ganetespib, which is currently being 202 evaluated in clinical trials as an anti-cancer drug (23), may be of therapeutic benefit to 203 hypertensive OSA patients who do not respond to CPAP or standard anti-hypertensive 204
agents. 205
Finally, independent of OSA, the balance between HIF-1α and HIF-2α 206 establishes a redox balance in the carotid body, which in turn establishes a set point for 207 sympathetic nervous system activity, which is a major determinant of blood pressure. 
